BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29990501)

  • 21. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.
    Simmons JL; Pierce CJ; Al-Ejeh F; Boyle GM
    Sci Rep; 2017 Sep; 7(1):10909. PubMed ID: 28883623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
    Reed JA; Loganzo F; Shea CR; Walker GJ; Flores JF; Glendening JM; Bogdany JK; Shiel MJ; Haluska FG; Fountain JW
    Cancer Res; 1995 Jul; 55(13):2713-8. PubMed ID: 7796391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contextual role of E2F1 in suppression of melanoma cell motility and invasiveness.
    Meng P; Bedolla RG; Yun H; Fitzpatrick JE; Kumar AP; Ghosh R
    Mol Carcinog; 2019 Sep; 58(9):1701-1710. PubMed ID: 31124185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.
    Zingg D; Debbache J; Peña-Hernández R; Antunes AT; Schaefer SM; Cheng PF; Zimmerli D; Haeusel J; Calçada RR; Tuncer E; Zhang Y; Bossart R; Wong KK; Basler K; Dummer R; Santoro R; Levesque MP; Sommer L
    Cancer Cell; 2018 Jul; 34(1):69-84.e14. PubMed ID: 30008323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
    Ishii J; Sato H; Sakaeda M; Shishido-Hara Y; Hiramatsu C; Kamma H; Shimoyamada H; Fujiwara M; Endo T; Aoki I; Yazawa T
    Pathol Int; 2013 Mar; 63(3):158-68. PubMed ID: 23530560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reciprocal Regulation of BRN2 and NOTCH1/2 Signaling Synergistically Drives Melanoma Cell Migration and Invasion.
    Fane ME; Chhabra Y; Spoerri L; Simmons JL; Ludwig R; Bonvin E; Goding CR; Sturm RA; Boyle GM; Haass NK; Piper M; Smith AG
    J Invest Dermatol; 2022 Jul; 142(7):1845-1857. PubMed ID: 34958806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.
    Damsky W; Micevic G; Meeth K; Muthusamy V; Curley DP; Santhanakrishnan M; Erdelyi I; Platt JT; Huang L; Theodosakis N; Zaidi MR; Tighe S; Davies MA; Dankort D; McMahon M; Merlino G; Bardeesy N; Bosenberg M
    Cancer Cell; 2015 Jan; 27(1):41-56. PubMed ID: 25584893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOXQ1 controls the induced differentiation of melanocytic cells.
    Bagati A; Bianchi-Smiraglia A; Moparthy S; Kolesnikova K; Fink EE; Kolesnikova M; Roll MV; Jowdy P; Wolff DW; Polechetti A; Yun DH; Lipchick BC; Paul LM; Wrazen B; Moparthy K; Mudambi S; Morozevich GE; Georgieva SG; Wang J; Shafirstein G; Liu S; Kandel ES; Berman AE; Box NF; Paragh G; Nikiforov MA
    Cell Death Differ; 2018 Jun; 25(6):1040-1049. PubMed ID: 29463842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple melanoma susceptibility factors function in an ultraviolet radiation response pathway in skin.
    Giles N; Pavey S; Pinder A; Gabrielli B
    Br J Dermatol; 2012 Feb; 166(2):362-71. PubMed ID: 21923753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-Wide Overexpression Screen Identifies Genes Able to Bypass p16-Mediated Senescence in Melanoma.
    Lee WJ; Škalamera D; Dahmer-Heath M; Shakhbazov K; Ranall MV; Fox C; Lambie D; Stevenson AJ; Yaswen P; Gonda TJ; Gabrielli B
    SLAS Discov; 2017 Mar; 22(3):298-308. PubMed ID: 27872202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
    Jonsson A; Tuominen R; Grafström E; Hansson J; Egyhazi S
    J Invest Dermatol; 2010 Dec; 130(12):2809-17. PubMed ID: 20703244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A.
    Arozarena I; Sanchez-Laorden B; Packer L; Hidalgo-Carcedo C; Hayward R; Viros A; Sahai E; Marais R
    Cancer Cell; 2011 Jan; 19(1):45-57. PubMed ID: 21215707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes.
    Bloethner S; Hemminki K; Thirumaran RK; Chen B; Mueller-Berghaus J; Ugurel S; Schadendorf D; Kumar R
    Melanoma Res; 2006 Aug; 16(4):297-307. PubMed ID: 16845325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene.
    Kobi D; Steunou AL; Dembélé D; Legras S; Larue L; Nieto L; Davidson I
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):404-18. PubMed ID: 20337985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells.
    Flammiger A; Besch R; Cook AL; Maier T; Sturm RA; Berking C
    J Invest Dermatol; 2009 Apr; 129(4):945-53. PubMed ID: 18923447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation.
    Vachtenheim J; Ondrušová L
    Exp Dermatol; 2015 Jul; 24(7):481-4. PubMed ID: 25866058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
    Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
    Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of p16(INK4a), the product of a tumor suppressor gene for melanoma, is upregulated in human melanocytes by UVB irradiation.
    Piepkorn M
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):741-5. PubMed ID: 10775848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis.
    Cook AL; Sturm RA
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):611-26. PubMed ID: 18983536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects on proliferation and melanogenesis by inhibition of mutant BRAF and expression of wild-type INK4A in melanoma cells.
    Rotolo S; Diotti R; Gordon RE; Qiao RF; Yao Z; Phelps RG; Dong J
    Int J Cancer; 2005 May; 115(1):164-9. PubMed ID: 15657897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.